EU pharmacovigilance challenges

EU pharmacovigilance challenges

National Authorization
Drug Events
Baycol/Lipobay cerivastatin 1997: Approved
Company: Bayer Indication: Hypercholesterolemia June 2001: Spanish and U.K. authorities agree with Bayer on an "Urgent Safety Restriction," introducing

Read the full 301 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE